Current evidence on switching between biologic therapies for Still’s disease: A systematic literature review
Open Access
- 18 July 2025
- journal article
- review article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 74, 152789
Abstract
No abstract availableKeywords
Funding Information
- Novartis
This publication has 64 references indexed in Scilit:
- Diagnosis and treatment of adult-onset Still’s disease: a concise summary of the German society of rheumatology S2 guidelineZeitschrift für Rheumatologie, 2022
- The Conundrum of Lung Disease and Drug Hypersensitivity‐like Reactions in Systemic Juvenile Idiopathic ArthritisArthritis & Rheumatology, 2022
- 2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic ArthritisArthritis Care & Research, 2022
- Early Treatment and IL1RN Single‐Nucleotide Polymorphisms Affect Response to Anakinra in Systemic Juvenile Idiopathic ArthritisArthritis & Rheumatology, 2020
- Tapering Canakinumab Monotherapy in Patients With Systemic Juvenile Idiopathic Arthritis in Clinical Remission: Results From a Phase IIIb/IV Open‐Label, Randomized StudyArthritis & Rheumatology, 2020
- Efficacy and Safety of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis With and Without Fever at Baseline: Results From an Open‐Label, Active‐Treatment Extension StudyArthritis & Rheumatology, 2020
- Comparisons of the outcomes between early and late tocilizumab treatment in systemic juvenile idiopathic arthritisRheumatology International, 2016
- Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?Arthritis & Rheumatology, 2014
- Randomized, Double‐Blind, Placebo‐Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic ArthritisArthritis & Rheumatology, 2014
- Efficacy of Tocilizumab in Conventional Treatment–Refractory Adult‐Onset Still's Disease: Multicenter Retrospective Open‐Label Study of Thirty‐Four PatientsArthritis & Rheumatology, 2014